156 related articles for article (PubMed ID: 32921411)
1. N-glycosylation of Siglec-15 decreases its lysosome-dependent degradation and promotes its transportation to the cell membrane.
Chen X; Dang X; Song J; Wang G; Liu C; Cui L; Huang Z
Biochem Biophys Res Commun; 2020 Nov; 533(1):77-82. PubMed ID: 32921411
[TBL] [Abstract][Full Text] [Related]
2. Siglec-15 promotes the migration of liver cancer cells by repressing lysosomal degradation of CD44.
Liu W; Ji Z; Wu B; Huang S; Chen Q; Chen X; Wei Y; Jiang J
FEBS Lett; 2021 Sep; 595(17):2290-2302. PubMed ID: 34328657
[TBL] [Abstract][Full Text] [Related]
3. Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy.
Wang J; Sun J; Liu LN; Flies DB; Nie X; Toki M; Zhang J; Song C; Zarr M; Zhou X; Han X; Archer KA; O'Neill T; Herbst RS; Boto AN; Sanmamed MF; Langermann S; Rimm DL; Chen L
Nat Med; 2019 Apr; 25(4):656-666. PubMed ID: 30833750
[TBL] [Abstract][Full Text] [Related]
4. Siglec-15 as multifunctional molecule involved in osteoclast differentiation, cancer immunity and microbial infection.
Huang R; Zheng J; Shao Y; Zhu L; Yang T
Prog Biophys Mol Biol; 2023 Jan; 177():34-41. PubMed ID: 36265694
[TBL] [Abstract][Full Text] [Related]
5. Glycosylation affects the stability and subcellular distribution of human PAT1 protein.
Luo H; Zhao L; Ji X; Zhang X; Jin Y; Liu W
FEBS Lett; 2017 Feb; 591(4):613-623. PubMed ID: 28117901
[TBL] [Abstract][Full Text] [Related]
6. Siglec-15 regulates osteoclast differentiation by modulating RANKL-induced phosphatidylinositol 3-kinase/Akt and Erk pathways in association with signaling Adaptor DAP12.
Kameda Y; Takahata M; Komatsu M; Mikuni S; Hatakeyama S; Shimizu T; Angata T; Kinjo M; Minami A; Iwasaki N
J Bone Miner Res; 2013 Dec; 28(12):2463-75. PubMed ID: 23677868
[TBL] [Abstract][Full Text] [Related]
7. Immunopositivity for Siglec-15 in gastric cancer and its association with clinical and pathological parameters.
Quirino MWL; Pereira MC; Deodato de Souza MF; Pitta IDR; Da Silva Filho AF; Albuquerque MSS; Albuquerque APB; Martins MR; Pitta MGDR; Rêgo MJBM
Eur J Histochem; 2021 Mar; 65(1):. PubMed ID: 33666065
[TBL] [Abstract][Full Text] [Related]
8. The interaction between Siglec-15 and tumor-associated sialyl-Tn antigen enhances TGF-β secretion from monocytes/macrophages through the DAP12-Syk pathway.
Takamiya R; Ohtsubo K; Takamatsu S; Taniguchi N; Angata T
Glycobiology; 2013 Feb; 23(2):178-87. PubMed ID: 23035012
[TBL] [Abstract][Full Text] [Related]
9. Nano-LYTACs for Degradation of Membrane Proteins and Inhibition of CD24/Siglec-10 Signaling Pathway.
Wang K; Yu A; Liu K; Feng C; Hou Y; Chen J; Ma S; Huang L; Dai X
Adv Sci (Weinh); 2023 May; 10(13):e2300288. PubMed ID: 36866919
[TBL] [Abstract][Full Text] [Related]
10. The diverse functions of Siglec-15 in bone remodeling and antitumor responses.
Kang FB; Chen W; Wang L; Zhang YZ
Pharmacol Res; 2020 May; 155():104728. PubMed ID: 32112821
[TBL] [Abstract][Full Text] [Related]
11. NCU-G1 is a highly glycosylated integral membrane protein of the lysosome.
Schieweck O; Damme M; Schröder B; Hasilik A; Schmidt B; Lübke T
Biochem J; 2009 Jul; 422(1):83-90. PubMed ID: 19489740
[TBL] [Abstract][Full Text] [Related]
12. TM7SF1 (GPR137B): a novel lysosome integral membrane protein.
Gao J; Xia L; Lu M; Zhang B; Chen Y; Xu R; Wang L
Mol Biol Rep; 2012 Sep; 39(9):8883-9. PubMed ID: 22729905
[TBL] [Abstract][Full Text] [Related]
13. Siglec-15 is a potential therapeutic target for postmenopausal osteoporosis.
Kameda Y; Takahata M; Mikuni S; Shimizu T; Hamano H; Angata T; Hatakeyama S; Kinjo M; Iwasaki N
Bone; 2015 Feb; 71():217-26. PubMed ID: 25460183
[TBL] [Abstract][Full Text] [Related]
14. Siglec-15: an immune system Siglec conserved throughout vertebrate evolution.
Angata T; Tabuchi Y; Nakamura K; Nakamura M
Glycobiology; 2007 Aug; 17(8):838-46. PubMed ID: 17483134
[TBL] [Abstract][Full Text] [Related]
15. The Lysosome Pathway Degrades CD81 on the Cell Surface by Poly-ubiquitination and Clathrin-Mediated Endocytosis.
Hosokawa K; Ishimaru H; Watanabe T; Fujimuro M
Biol Pharm Bull; 2020 Mar; 43(3):540-545. PubMed ID: 31902824
[TBL] [Abstract][Full Text] [Related]
16. Delivery of endocytosed membrane proteins to the lysosome.
Pryor PR; Luzio JP
Biochim Biophys Acta; 2009 Apr; 1793(4):615-24. PubMed ID: 19167432
[TBL] [Abstract][Full Text] [Related]
17. The ocular albinism type 1 gene product is an N-glycoprotein but glycosylation is not required for its subcellular distribution.
Shen B; Orlow SJ
Pigment Cell Res; 2001 Dec; 14(6):485-90. PubMed ID: 11775061
[TBL] [Abstract][Full Text] [Related]
18. Glycosylation of tetraspanin Tspan-1 at four distinct sites promotes its transition through the endoplasmic reticulum.
Scholz CJ; Sauer G; Deissler H
Protein Pept Lett; 2009; 16(10):1244-8. PubMed ID: 19508227
[TBL] [Abstract][Full Text] [Related]
19. Targeted Protein Degradation Mediated by Genetically Engineered Lysosome-Targeting Exosomes.
Wang T; Sun L; Ren T; Hou M; Long Y; Jiang JH; He J
Nano Lett; 2023 Oct; 23(20):9571-9578. PubMed ID: 37823825
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of the asparagine-linked oligosaccharides on siglec-5, siglec-7 and siglec-8, expressed in a CHO cell line, and their contribution to ligand recognition.
Freeman S; Birrell HC; D'Alessio K; Erickson-Miller C; Kikly K; Camilleri P
Eur J Biochem; 2001 Mar; 268(5):1228-37. PubMed ID: 11231274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
